The US dominates the global cannabis market, generating 81% total value share in 2021. At the same time, European countries account for 8% share of worldwide value following Canada with 9%. Poland is responsible for an 8% value share of European countries; adult-use is prohibited by law, medical cannabis is only legal with a prescription, while CBD is freely available.
Indonesia is the second largest cigarette market in the world, and is the largest market meaningfully accessible to international companies, given trading restrictions in China. Smoking levels remain high and despite economic and regulatory threats to demand, this remains a key market to watch for tobacco.
As the first cracks appear in the pan-European prohibitionary edifice, Germany is about to embark on a legalisation journey of seismic proportions and far-reaching ripple effects. Could this be the catalyst that will ultimately shift the green limelight onto European markets?
The US and Canada are arguably the most important markets in cannabis. Knowing each regions' regulatory, attitudinal, and market developments towards medical and recreational cannabis is critical to finding opportunity and understanding the future of one of the most exciting, high-growth industries. This article highlights key trends for the US and Canada drawn from Euromonitor's comprehensive cannabis reports that cover each market.
The tobacco industry in the Middle East and North Africa (MENA) is anticipated to continue growing, owing to cultural norms and habit persistence, an increase in female smokers in selected markets, and increased demand for tobacco alternatives across e-vapour products and heated tobacco.